CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 27 enrolled
Drug / intervention
Visualase Thermal Therapy +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01792024
NCT01792024N/ACompleted
CompareCT.gov

Phase II Evaluation of MR-Guided Laser Induced Interstitial Thermal Therapy (LITT) for Prostate Cancer

University of Chicago·interventional·Posted Feb 15, 2013·Updated Mar 13, 2018

In Brief

A clinical study evaluating Visualase Thermal Therapy and magnetic resonance imaging for Stage I Prostate Cancer and Stage II Prostate Carcinoma. Completed, enrolled 27 participants across 1 site.

Detailed Summary

This phase II trial studies how well magnetic resonance (MR)-guided laser interstitial thermal therapy works in treating patients with prostate cancer. Laser therapy uses intense, narrow beams of light to cut and destroy tissue and may help treat prostate cancer

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStage I Prostate Cancer, Stage II Prostate Carcinoma
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 15, 2013
Enrollment StartJan 28, 2013
Primary CompletionSep 16, 2015
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 13.4 years ago

Interventions

Visualase Thermal Therapydevice

MR guided laser ablation of prostate cancer

magnetic resonance imagingprocedure

Undergo MR-guided LITT